Home/Filings/4/0000899243-22-033957
4//SEC Filing

SOFTBANK VISION FUND (AIV M1) L.P. 4

Accession 0000899243-22-033957

CIK 0001645842other

Filed

Oct 20, 8:00 PM ET

Accepted

Oct 21, 4:30 PM ET

Size

12.0 KB

Accession

0000899243-22-033957

Insider Transaction Report

Form 4
Period: 2022-10-19
Transactions
  • Other

    Common Stock

    2022-10-1926,614,2190 total(indirect: See footnotes)
Transactions
  • Other

    Common Stock

    2022-10-1926,614,2190 total(indirect: See footnotes)
Transactions
  • Other

    Common Stock

    2022-10-1926,614,2190 total(indirect: See footnotes)
Transactions
  • Other

    Common Stock

    2022-10-1926,614,2190 total(indirect: See footnotes)
Footnotes (3)
  • [F1]Pursuant to the Merger Agreement, dated July 24, 2022 (the "Merger Agreement"), by and among the Issuer, Ginkgo Bioworks Holdings, Inc. ("Ginkgo") and Pepper Merger Subsidiary Inc., the Issuer became an indirect wholly owned subsidiary of Ginkgo upon consummation of the merger on October 19, 2022 (the "Effective Time"), as provided for in the Merger Agreement. At the Effective Time, each share of the Issuer's common stock was automatically cancelled, extinguished and converted into the right to receive 0.9179 shares of Class A common stock of Ginkgo, with fractional shares paid in cash, without interest.
  • [F2]The securities reported herein are held of record by SVF Excalibur (Cayman) Limited, which is a wholly owned subsidiary of SVF Endurance (Cayman) Limited, which is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. SB Investment Advisers (UK) Limited has been appointed as alternative investment fund manager ("AIFM") and is exclusively responsible for managing SoftBank Vision Fund (AIV M1) L.P. in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly.
  • [F3]As AIFM of SoftBank Vision Fund (AIV M1) L.P., SB Investment Advisers (UK) Limited is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund (AIV M1) L.P.'s investments. As a result, each of the reporting persons may be deemed to share beneficial ownership of the securities reported herein, but disclaims beneficial ownership except to the extent of the pecuniary interest therein.

Issuer

Zymergen Inc.

CIK 0001645842

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001755143

Filing Metadata

Form type
4
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 4:30 PM ET
Size
12.0 KB